Notice: This company has been marked as potentially delisted and may not be actively trading. La Jolla Pharmaceutical (LJPC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Innoviva to Participate in the UBS Global Healthcare ConferenceNovember 12, 2024 | finance.yahoo.comAurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of GrowthNovember 8, 2024 | theglobeandmail.comAurinia stock jumps 14% on Q3 earnings, restructuring announcementNovember 7, 2024 | msn.comInnoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024October 15, 2024 | finance.yahoo.comLongboard Pharmaceuticals Shares Hit All-Time High on Takeover by LundbeckOctober 14, 2024 | marketwatch.comH. Lundbeck to Buy Longboard Pharmaceuticals for $2.6 Billion -- UpdateOctober 14, 2024 | marketwatch.comInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressMay 8, 2024 | finance.yahoo.comLa Jolla small business owners want lawful path to conduct business on the beachMarch 27, 2024 | msn.comScripps Green HospitalDecember 19, 2023 | health.usnews.comLa Jolla Pharmaceutical (NASDAQ: LJPC)September 25, 2023 | fool.comHepatorenal Syndrome Treatment Global Market Report 2023July 27, 2023 | finance.yahoo.comThalassemia Market Research | 2023-2030May 16, 2023 | marketwatch.comResults from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet ...May 11, 2023 | businesswire.comKidney (Renal) Fibrosis Market Report | Research Across The World 2031May 10, 2023 | marketwatch.comKidney Fibrosis Treatment Market Dynamics and Drivers: 2023-2031May 8, 2023 | marketwatch.comBased on recent market research, the Kidney/Renal Fibrosis Treatment market is set to experience robust growth, with a CAGR of 7% from 2023 to 2030.May 5, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market Historical Trends and Future Prospect till 2031May 4, 2023 | marketwatch.comLa Jolla High SchoolMay 3, 2023 | usnews.comCan The Proposed Antibiotic For Multidrug-Resistant Infections Fuel Innoviva's Revenue Growth?April 19, 2023 | markets.businessinsider.comThalassemia Market Complete Overview till 2030April 8, 2023 | marketwatch.comKidney Fibrosis Treatment Market-An Exclusive Study On Upcoming Trends And Growth Opportunities From 2023-2030April 7, 2023 | marketwatch.comKidney/Renal Fibrosis Treatment Market Size By 2031April 6, 2023 | marketwatch.comGlobal Thalassemia Market Size 2023 to 2026 Size and Share Survey ReportMarch 27, 2023 | marketwatch.comKidney Fibrosis Treatment Market Major Players, Anlysis and Forecast till 2031March 22, 2023 | marketwatch.comKidney/Renal Fibrosis Treatment Market Analysis 2023-2028, Newly Upgraded ReportMarch 20, 2023 | marketwatch.comScripps La Jolla HospitalsMarch 18, 2023 | health.usnews.comFibrodysplasia Ossificans Progressiva Drug Market Share, Segmentation and Forecast 2023-2028March 17, 2023 | marketwatch.comGlobal Fibrodysplasia Ossificans Progressiva Drug Market Size by Application (Hospital, Clinic, Research Center) Forecast from 2023 to 2028March 17, 2023 | marketwatch.comHeavy Metal Poisoning Drugs Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027March 15, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market Research Report 2023-2028 with Top Countries DataMarch 13, 2023 | marketwatch.comGlobal Thalassemia Market Growth Prospects, Geography, Drivers, and Restraints 2023 – 2030 By VMReportsMarch 12, 2023 | marketwatch.comKidney (Renal) Fibrosis Market Potential Analysis, by Trending Growth and CAGR 2023 to 2028March 10, 2023 | marketwatch.comUC San Diego Health-La Jolla and Hillcrest HospitalsFebruary 25, 2023 | health.usnews.comKidney Fibrosis Treatment Market Size 2023 : Emerging Technologies, Opportunity and Forecast to 2028February 18, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market is Booming in Near Future 2023-2028February 16, 2023 | marketwatch.comKidney Fibrosis Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2029February 15, 2023 | marketwatch.comJohnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&DFebruary 13, 2023 | benzinga.comThalassemia Market Growth and Status Explored in a New Research Report 2028February 9, 2023 | marketwatch.comLa Jolla, United States - Weather Forecasts | Maps | News - Yahoo WeatherFebruary 8, 2023 | yahoo.comKidney Fibrosis Treatment Market is booming in near Future 2023-2028January 20, 2023 | marketwatch.comKidney (Renal) Fibrosis Market 2023 : Detailed Analysis of Industry, Potential Growth, Attractive Valuation and Growth Forecast Up to 2028January 10, 2023 | marketwatch.comLa Jolla CoveDecember 31, 2022 | travel.usnews.comKidney (Renal) Fibrosis Market Size 2023 : Segment Overview, Company Profiles, Regional Analysis and Forecast 2028December 17, 2022 | marketwatch.comThis market report on Vasopressin for Vasoplegic Shock provides broad description of this industry.December 9, 2022 | marketwatch.comKidney (Renal) Fibrosis Market 2022 : Advance Technology, Latest Trend and Future Expansion by 2028 | 107 Pages ReportOctober 18, 2022 | marketwatch.comEverest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal InfectionsOctober 7, 2022 | markets.businessinsider.comLJPC Dec 2022 5.000 call(CONTRASeptember 2, 2022 | finance.yahoo.comTrading was temporarily halted for "LJPC" at 07:08 PM with a stated reason of "News pending."August 22, 2022 | marketbeat.comLa Jolla Pharmaceutical (NASDAQ:LJPC) Upgraded at StockNews.comStockNews.com raised shares of La Jolla Pharmaceutical from a "hold" rating to a "buy" rating in a research report on Wednesday.August 17, 2022 | marketbeat.comEverest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in TaiwanAugust 11, 2022 | markets.businessinsider.com Get La Jolla Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for LJPC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode in 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW LJPC Media Mentions By Week LJPC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LJPC News Sentiment▼0.000.62▲Average Medical News Sentiment LJPC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LJPC Articles This Week▼00▲LJPC Articles Average Week Get La Jolla Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for LJPC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Autolus Therapeutics News VectivBio News Ginkgo Bioworks News Kodiak Sciences News Tourmaline Bio News ProKidney News Sangamo Therapeutics News MeiraGTx News Allogene Therapeutics News Monte Rosa Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LJPC) was last updated on 1/1/2025 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTarget More Reliable Returns in 2025[LIVE] How the Pros are Trading Options in 2025 Charles Payne reveals beginner-friendly options strategies ...Unstoppable Prosperity | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding La Jolla Pharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share La Jolla Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
